| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 44,47% | 77,62% | 47,90% | · |
| NORDEA 1-ASIA EX JAPAN EQUITY FUND AP-EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 44,47% | 64,49% | 35,16% | 131,59% |
| AMUNDI FUNDS ASIA EQUITY FOCUS R2 USD (C) | RVI ASIA EX-JAPÓN | 44,45% | 84,06% | 52,43% | · |
| ARTEMIS FUNDS (LUX) - SMARTGARP GLOBAL EMERGING MARKETS EQUITY B USD CAP | RVI EMERGENTES | 44,44% | 95,03% | 90,58% | · |
| NINETY ONE GSF EMERGING MARKETS EQUITY FUND JX ACC USD | RVI EMERGENTES | 44,44% | 101,14% | 69,95% | · |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (GBP) P-ACC | RVI EMERGENTES | 44,44% | 79,69% | 38,90% | 119,21% |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY IXX GBP | RVI EMERGENTES | 44,43% | · | · | · |
| DWS ESG BIOTECH FC | RVI BIOTECNOLOGÍA | 44,42% | 53,14% | 37,56% | · |
| BNP PARIBAS JAPAN SMALL CAP CLASSIC H EUR CAP | RVI JAPÓN SMALL/MID CAP | 44,40% | 125,55% | 162,45% | 349,61% |
| HSBC GIF GLOBAL EMERGING MARKETS EQUITY IC USD | RVI EMERGENTES | 44,40% | 79,72% | 48,87% | 140,73% |
